The Perirolandic Sign: A Unique Imaging Finding Observed in Association with Polymerase γ-Related Disorders

REFERENCES

1. 1.↵
   1. Copeland WC

   . The mitochondrial DNA polymerase in health and disease. Subcell Biochem 2010;50:211–22 doi:10.1007/978-90-481-3471-7_11 pmid:20012584

   CrossRefPubMed
2. 2.↵
   1. Stumpf JD,
   2. Saneto RP,
   3. Copeland WC

   . Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol 2013;5:a011395 doi:10.1101/cshperspect.a011395 pmid:23545419

   Abstract/FREE Full Text
3. 3.↵
   1. Zsurka G,
   2. Kunz WS

   . Mitochondrial dysfunction and seizures: the neuronal energy crisis. Lancet Neurol 2015;14:956–96 doi:10.1016/S1474-4422(15)00148-9 pmid:26293567

   CrossRefPubMed
4. 4.↵
   1. Anagnostou ME,
   2. Ng YS,
   3. Taylor RW, et al

   . Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: a clinical and molecular genetic review. Epilepsia 2016;57:1531–45 doi:10.1111/epi.13508 pmid:27554452

   CrossRefPubMed
5. 5.↵
   1. Rahman S,
   2. Copeland WC

   . POLG-related disorders and their neurological manifestations. Nat Rev Neurol 2019;15:40–52 doi:10.1038/s41582-018-0101-0 pmid:30451971

   CrossRefPubMed
6. 6.↵
   1. Nurminen A,
   2. Farnum GA,
   3. Kaguni LS

   . Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database. BBA Clin 2017;7:147–56 doi:10.1016/j.bbacli.2017.04.001 pmid:28480171

   CrossRefPubMed
7. 7.↵
   1. Adam MR,
   2. Ardinger HH,
   3. Pagon RA

   1. Cohen BH,
   2. Chinnery PF,
   3. Copeland WC

   . POLG-related disorders. In: Adam MR, Ardinger HH, Pagon RA. eds. GeneReviews. University of Washington; 2018
8. 8.↵
   1. Hikmat O,
   2. Eichele T,
   3. Tzoulis C, et al

   . Understanding the epilepsy in POLG related disease. Int J Mol Sci 2017;18 doi:10.3390/ijms18091845 pmid:28837072

   CrossRefPubMed
9. 9.↵
   1. Vein AA,
   2. van Emde Boas W

   . Kozhevnikov epilepsy: the disease and its eponym. Epilepsia 2011;52:212–18 doi:10.1111/j.1528-1167.2010.02900.x pmid:21204824

   CrossRefPubMed
10. 10.↵
    1. Thomas JE,
    2. Reagan TJ,
    3. Klass DW

    . Epilepsia partialis continu: a review of 32 cases. Arch Neurol 1977;34:266–75 doi:10.1001/archneur.1977.00500170020003 pmid:404996

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Mameniškienė R,
    2. Wolf P

    . Epilepsia partialis continua: a review. Seizure 2017;44:74–80 doi:10.1016/j.seizure.2016.10.010 pmid:28029552

    CrossRefPubMed
12. 12.↵
    1. Bien CG,
    2. Widman G,
    3. Urbach H, et al

    . The natural history of Rasmussen’s encephalitis. Brain 2002;125:1751–59 doi:10.1093/brain/awf176 pmid:12135966

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Park S,
    2. Kang HC,
    3. Lee JS, et al

    . Alpers-Huttenlocher syndrome first presented with hepatic failure: can liver transplantation be considered as treatment option? Pediatr Gastroenterol Hepatol Nutr 2017;20:259–62 doi:10.5223/pghn.2017.20.4.259 pmid:29302508

    CrossRefPubMed
14. 14.↵
    1. Wolf NI,
    2. Rahman S,
    3. Schmitt B, et al

    . Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 2009;50:1596–1607 doi:10.1111/j.1528-1167.2008.01877.x pmid:19054397

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Lagan NC,
    2. Gorman KM,
    3. Shahwan A, et al

    . Teaching Video Neuro: epilepsia partialis continua in an adolescent with preexisting focal epilepsy. Neurology 2017;89:e274–75 doi:10.1212/WNL.0000000000004713 pmid:29203537

    CrossRefPubMed
16. 16.↵
    1. Papandreou A,
    2. Rahman S,
    3. Fratter C, et al

    . Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease. J Inherit Metab Dis 2018;41:1275–83 doi:10.1007/s10545-018-0227-7 pmid:30167885

    CrossRefPubMed
17. 17.↵
    1. Ikawa M,
    2. Yoneda M,
    3. Muramatsu T, et al

    . Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients. Mitochondrion 2013;13:676–80 doi:10.1016/j.mito.2013.09.007 pmid:24095972

    CrossRefPubMed
18. 18.↵
    1. Saneto RP,
    2. Lee I-C,
    3. Koenig MK, et al

    . POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 2010;19:140–46 doi:10.1016/j.seizure.2010.01.002 pmid:20138553

    CrossRefPubMedWeb of Science
19. 19.↵
    1. White ML,
    2. Zhang Y,
    3. Helvey JT, et al

    . Anatomical patterns and correlated MRI findings of non-perinatal hypoxic-ischaemic encephalopathy. Br J Radiol 2013;86:20120464 doi:10.1259/bjr.20120464 pmid:23255548

    Abstract/FREE Full Text
20. 20.↵
    1. Takanashi JI,
    2. Barkovich AJ,
    3. Cheng SF, et al

    . Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders. AJNR Am J Neuroradiol 2003;24:1184–87 pmid:12812952

    Abstract/FREE Full Text
21. 21.↵
    1. Zuccoli GE,
    2. Siddiqui N,
    3. Bailey A, et al

    . Neuroimaging findings in pediatric Wernicke encephalopathy: a review. Neuroradiology 2010;52:523–29 doi:10.1007/s00234-009-0604-x pmid:19844698

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Shah T,
    2. Purohit S,
    3. Raval M

    . Imaging in maple syrup urine disease. Indian J Pediatr 2018;85:927–28 doi:10.1007/s12098-018-2696-y pmid:29744745

    CrossRefPubMed
23. 23.↵
    1. Magill ST,
    2. Han SJ,
    3. Li J, et al

    . Resection of primary motor cortex tumors: feasibility and surgical outcomes. J Neurosurg 2018;129:961–72 doi:10.3171/2017.5.JNS163045 pmid:29219753

    CrossRefPubMed
24. 24.↵
    1. Smith AB,
    2. Smirniotopoulos JG,
    3. Rushing EJ, et al

    . Bilateral thalamic lesions. AJR Am J Roentgenol 2009;192:W53–62 doi:10.2214/AJR.08.1585 pmid:19155381

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Tuttle C,
    2. Boto J,
    3. Martin S, et al

    . Neuroimaging of acute and chronic unilateral and bilateral thalamic lesions. Insights Imaging 2019;10:24 doi:10.1186/s13244-019-0700-3 pmid:30796553

    CrossRefPubMed